Placement Announced
ADARx Pharmaceuticals placement
US$89m raised
Announced 24 Sep 2026 · NASDAQ: ADRX · US$17.00 cash per share
Advisers
ADARx Pharmaceuticals
Issuer
Not disclosed
Lead managers
- Placement agent
- Issuer
- ADARx Pharmaceuticals
- Issuer based in
- United States
- Sector
- Biotech
- Tags
- Biotech, Drug Development
Similar deals
- Remix Therapeutics placement Jun 2026 · US$100m · Biotech
- Research Alliance Corporation III placement Jul 2026 · US$100m · Biotech
- Parabilis Medicines placement Jun 2026 · US$75m · Biotech
- Skye Bioscience placement Aug 2026 · US$68m · Biotech
- Redx Pharma placement Aug 2026 · US$125m · Biotech
Sources
- 28 Sep 2026 Final IPO prospectus (424B4), ADARx Pharmaceuticals, Inc. sec.gov

